Zogenix’s seizure drug filing fails to pass U.S. FDA scrutiny
(Reuters) – The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc’s…
by October Gallery
by October Gallery
(Reuters) – The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc’s…